News

Silent Liver Disease Now A Childhood Crisis
MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...
GEN - Genetic Engineering and Biotechnology News22h
How Climate Changes Are Impacting Infectious Diseases
The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...
Rolling Out5d
Non-reactive HIV test might not mean what you think
Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...
Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled analysis including data from the 17-HMedIdeS-14 study, an international ...
Shefali Jariwala Death: What Is Glutathione? Oral, Topical Or Intravenous (IV), Decoding The Skin Treatment
Both glutathione and vitamin C are primarily used for skin whitening, detoxification and improving skin texture.
manilatimes4d
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI ...
Antiviral activity will be evaluated by assessing changes in viral parameters, including HSV type 2 (HSV-2) shedding rate and levels of HSV-2 DNA ... with most people with initial symptomatic genital ...
The Manila Times2d
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...
Actinogen Medical Limited: Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant ...
PetVivo Holdings, Inc. (OTC:PETV) Q4 2025 Earnings Call Transcript
PetVivo Holdings, Inc. (OTC: PETV) Q4 2025 Earnings Call Transcript June 30, 2025 ...
Rolling Out5d
When your negative HIV test means you need another
Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...
Pharmabiz4d
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...